HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Dasgupta, A. Articles by Wilson, D. W. Search for Related Content PubMed PubMed Citation Articles by Dasgupta, A. Articles by Wilson, D. W. Agricola Articles by Dasgupta, A. Articles by Wilson, D. W.

Evaluation of the primary effect of brefeldin A treatment upon herpes simplex virus assembly

Department of Developmental and Molecular Biology, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, USA¹

Author for correspondence: Duncan Wilson. Fax +1 718 430 8567. e-mail wilson{at}aecom.yu.edu

Addition of the drug brefeldin A (BFA) to cells infected by herpes simplex virus (HSV) type 1 is known to result in a complex pattern of defects in particle assembly. BFA-treated, infected cells accumulate perinuclear enveloped virions and non-enveloped (‘naked’) cytoplasmic capsids, and it has been difficult to interpret these data in terms of the assembly pathway of HSV and the known effects of BFA on the secretory apparatus. Since BFA is a cytotoxic drug, and earlier studies commonly examined the effects of long-term BFA incubations on infected cells, it was hypothesized that the drug could have pleiotropic and indirect effects on HSV assembly. To test this, use was made of an HSV synchronized assembly assay, in which cells are infected with the virus mutant tsProt.A and maintained at 39 °C to induce reversible accumulation of a population of procapsids. By first adding BFA and then shifting these cells to 31 °C for 3 h to allow the accumulated procapsids to mature, it was possible to test the effect of short-term BFA treatment on only those HSV assembly events that are downstream of procapsid maturation. Under these conditions, it was found that procapsids matured and packaged the viral genome normally, but remained non-enveloped and failed to exit the nucleus. It is concluded that the primary effect of BFA on HSV replication is to inhibit budding at the inner nuclear membrane.

This article has been cited by other articles:

				A. Snyder, T. W. Wisner, and D. C. Johnson Herpes Simplex Virus Capsids Are Transported in Neuronal Axons without an Envelope Containing the Viral Glycoproteins J. Virol., November 15, 2006; 80(22): 11165 - 11177. [Abstract] [Full Text] [PDF]

				G. Remillard-Labrosse, G. Guay, and R. Lippe Reconstitution of Herpes Simplex Virus Type 1 Nuclear Capsid Egress In Vitro J. Virol., October 1, 2006; 80(19): 9741 - 9753. [Abstract] [Full Text] [PDF]

				A. Farnsworth and D. C. Johnson Herpes Simplex Virus gE/gI Must Accumulate in the trans-Golgi Network at Early Times and Then Redistribute to Cell Junctions To Promote Cell-Cell Spread. J. Virol., April 1, 2006; 80(7): 3167 - 3179. [Abstract] [Full Text] [PDF]

				S. Turcotte, J. Letellier, and R. Lippe Herpes Simplex Virus Type 1 Capsids Transit by the trans-Golgi Network, Where Viral Glycoproteins Accumulate Independently of Capsid Egress J. Virol., July 15, 2005; 79(14): 8847 - 8860. [Abstract] [Full Text] [PDF]

				T. del Rio, T. H. Ch'ng, E. A. Flood, S. P. Gross, and L. W. Enquist Heterogeneity of a Fluorescent Tegument Component in Single Pseudorabies Virus Virions and Enveloped Axonal Assemblies J. Virol., April 1, 2005; 79(7): 3903 - 3919. [Abstract] [Full Text] [PDF]